Alpha Tau to Participate in Sidoti Small-Cap Conference
Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW) will present at the Sidoti Small-Cap Virtual Conference on December 7th, 2023, to showcase their innovative alpha-radiation cancer therapy Alpha DaRT™.
11/29/2023 - 08:30 AM
JERUSALEM, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that management will present at the Sidoti Small-Cap Virtual Conference on Thursday, December 7th , 2023.
Founded in 2016, Alpha Tau is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.
Investor Relations Contact: IR@alphatau.com
What is Alpha Tau Medical Ltd.'s ticker symbol?
Alpha Tau Medical Ltd.'s ticker symbol is NASDAQ: DRTS, DRTSW.
What is the innovative cancer therapy developed by Alpha Tau Medical Ltd.?
Alpha Tau Medical Ltd. has developed the innovative alpha-radiation cancer therapy Alpha DaRT™.
When will Alpha Tau Medical Ltd. present at the Sidoti Small-Cap Virtual Conference?
Alpha Tau Medical Ltd. will present at the Sidoti Small-Cap Virtual Conference on December 7th, 2023.
Where can I register for Alpha Tau Medical Ltd.'s presentation at the Sidoti Small-Cap Virtual Conference?
You can register for Alpha Tau Medical Ltd.'s presentation at the Sidoti Small-Cap Virtual Conference at https://sidoti.zoom.us/webinar/register/WN_VNDWwCEtSeySoAVKVx38YQ
DRTS Rankings
#3415 Ranked by Stock Gains
DRTS Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
About DRTS
alpha tau medical (http://www.alphataumedical.com/) focuses on research, development and commercialization of alpha dart (diffusing alpha-emitters radiation therapy) for the treatment of solid cancer tumors. alpha dart technology, initially developed at tel aviv university, was shown to be effective and safe for treating different types of cancer in multiple animal studies. the company is running its first clinical trial in several sites in the eu. breakthrough technology for cancer treatment the alpha dart breakthrough technology utilizes alpha radiation to treat cancer and enables highly potent and conformal radiotherapy. alpha dart treats solid tumors with interstitial radioactive seeds that continually release short-lived alpha emitting atoms into the tumor.
